首页> 美国卫生研究院文献>Journal of Clinical Neurology (Seoul Korea) >Safety and Efficacy of Cerebrolysin in Infants with Communication Defects due to Severe Perinatal Brain Insult: A Randomized Controlled Clinical Trial

【2h】

Safety and Efficacy of Cerebrolysin in Infants with Communication Defects due to Severe Perinatal Brain Insult: A Randomized Controlled Clinical Trial

机译：严重围产期脑部感染导致沟通缺陷的婴儿中脑溶血素的安全性和有效性：一项随机对照临床试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background and PurposeThe neuroregenerative drug Cerebrolysin has demonstrated efficacy in improving cognition in adults with stroke and Alzheimer's disease. The aim of this study was to determine the efficacy and safety of Cerebrolysin in the treatment of communication defects in infants with severe perinatal brain insult.

机译：背景和目的神经再生药物脑溶血素已证明可改善成年人中风和阿尔茨海默氏病的认知。这项研究的目的是确定脑溶素治疗严重围产期脑部损伤的婴儿的沟通障碍的疗效和安全性。

著录项

期刊名称 Journal of Clinical Neurology (Seoul Korea)
作者
Sahar M.A. Hassanein; Shaymaa M. Deifalla; Moustafa El-Houssinie; Somaia A. Mokbel;
展开▼
作者单位

展开▼
年(卷),期 2016(12),1
年度 2016
页码 79–84
总页数 6
原文格式 PDF
正文语种
中图分类神经病学;
关键词
nootropic factor perinatal brain insult cerebrolysin infant Communication and Symbolic-Behavior-Scale-Developmental Profile communication defects symbolic speech development;

机译：促智因素;围产期脑损伤;脑溶素;婴儿;沟通和符号行为量表发展概况;沟通缺陷;言语发展;

相似文献

外文文献
中文文献
专利

1. Safety and Efficacy of Cerebrolysin in Infants with Communication Defects due to Severe Perinatal Brain Insult: A Randomized Controlled Clinical Trial [J] . Hassanein Sahar M.A., Deifalla Shaymaa M., El-Houssinie Moustafa, Journal of Clinical Neurology . 2016,第1期

机译：严重围产期脑部感染导致沟通缺陷的婴儿中脑溶血素的安全性和有效性：一项随机对照临床试验
2. Efficacy and safety of Cerebrolysin in moderate to moderately severe Alzheimer's disease: results of a randomized, double-blind, controlled trial investigating three dosages of Cerebrolysin. [J] . Alvarez XA, Cacabelos R, Sampedro C, European journal of neurology: the official journal of the European Federation of Neurological Societies . 2011,第1期

机译：脑溶素在中度至中度重度阿尔茨海默氏病中的功效和安全性：一项随机，双盲，对照试验的结果，该试验研究了三种脑溶素的剂量。
3. Efficacy and safety of dexanabinol in severe traumatic brain injury: results of a phase III randomised, placebo-controlled, clinical trial. [J] . Maas AI, Murray G, Henney H 3rd, Lancet Neurology . 2006,第1期

机译：地塞那酚在严重脑外伤中的疗效和安全性：III期随机，安慰剂对照的临床试验的结果。
4. A DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED CLINICAL TRIAL TO INVESTIGATE THE EFFICACY OF TIAMULIN IN THE CONTROL OF PORCINE PROLIFERATIVE ENTEROPATHY (PPE) AND PORCINE COLONIC SPIROCHAETOSIS (PCS) UNDER FIELD CONDITIONS [C] . J. Haugegaard, K. Moller, T.K. Jensen, Congress of the International Pig Veterinary Society . 2000

机译：一种双盲随机安慰剂对照临床试验，探讨硫霉素在野生植物中猪增殖肠病（PPE）和猪结肠螺旋肌肤症（PCS）的疗效
5. Phase II double-blinded randomized controlled clinical trial of chondroitinase ABC by intraspinal injection for treatment of severe chronic spinal cord injury in 60 pet dogs. [D] . Hu, Hilary. 2016

机译：脊髓内注射软骨素酶ABC的II期双盲随机对照临床试验，用于治疗60只宠物狗的严重慢性脊髓损伤。
6. Efficacy and safety of Cerebrolysin treatment in early recovery after acute ischemic stroke: a randomized placebo-controlled double-blinded multicenter clinical trial [O] . K Gharagozli, AA Harandi, S Houshmand, 2017

机译：脑溶素治疗早期恢复的疗效和安全性急性缺血性中风后：随机安慰剂对照双盲多中心临床试验
7. Correction to: Safety and efficacy of Cerebrolysin in acute brain injury and neurorecovery: CAPTAIN I—a randomized, placebo-controlled, double-blind, Asian-Pacific trial [O] . W. Poon, C. Matula, P. E. Vos, 2020

机译：矫正：急性脑损伤中脑损伤的安全性和疗效和神经妇幼的：I-A-A随机，安慰剂控制，双盲，亚太审判

Safety and Efficacy of Cerebrolysin in Infants with Communication Defects due to Severe Perinatal Brain Insult: A Randomized Controlled Clinical Trial

摘要

著录项

相似文献

相关主题

期刊订阅